Publicacións nas que colabora con Oreste Gualillo (120)

2024

  1. A retrospective study describing the acetabular consequences of Legg- Calve-Perthes disease

    BMC Musculoskeletal Disorders, Vol. 25, Núm. 1

  2. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration

    Pharmacological Research, Vol. 205

  3. Impact of Chondrocyte Inflammation on Glial Cell Activation: The Mediating Role of Nitric Oxide

    Cartilage

  4. Lipocalin-2 Serum Levels in Rheumatoid Arthritis Patients Treated with Adalimumab and Its Correlation with Proinflammatory Factors

    Mediators of inflammation, Vol. 2024, pp. 7264704

2023

  1. Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells

    Spine Journal, Vol. 23, Núm. 10, pp. 1549-1562

  2. Monomeric CRP regulates inflammatory responses in human intervertebral disc cells

    Bone and Joint Research, Vol. 12, Núm. 3, pp. 189-198

  3. Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer

    Antioxidants, Vol. 12, Núm. 12

  4. Poly(ethylene Glycol) Methyl Ether Methacrylate-Based Injectable Hydrogels: Swelling, Rheological, and In Vitro Biocompatibility Properties with ATDC5 Chondrogenic Lineage

    Polymers, Vol. 15, Núm. 24, pp. 4635

  5. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. A new immunometabolic perspective of intervertebral disc degeneration

    Nature Reviews Rheumatology, Vol. 18, Núm. 1, pp. 47-60

  2. Activation of Hypothalamic AMP-Activated Protein Kinase Ameliorates Metabolic Complications of Experimental Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 2, pp. 212-222

  3. Adipokines as targets in musculoskeletal immune and inflammatory diseases

    Drug Discovery Today, Vol. 27, Núm. 11

  4. Analgesic and antiinflammatory effects of Nigella orientalis L. seeds fixed oil: Pharmacological potentials and molecular mechanisms

    Phytotherapy Research, Vol. 36, Núm. 3, pp. 1372-1385

  5. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  6. Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review

    Pharmaceuticals, Vol. 15, Núm. 12

  7. Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  8. Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  9. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

  10. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. An update on the role of leptin in the immuno-metabolism of cartilage

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-16